Velusetrag - Wikiwand
Frontiers | Current Treatment Options and Therapeutic Insights for Gastrointestinal Dysmotility and Functional Gastrointestinal Disorders | Pharmacology
Clinical trial: the efficacy and tolerability of velusetrag, a selective 5‐HT4 agonist with high intrinsic activity, in chronic idiopathic constipation – a 4‐week, randomized, double‐blind, placebo‐controlled, dose–response study - Goldberg - 2010 -
Diabetic gastroparesis: current challenges and future prospects | CEG
VELUSETRAG
Pharmacological agents currently in clinical trials for disorders in neurogastroenterology. - Abstract - Europe PMC
Velusetrag - Wikipedia
Velusetrag | C25H36N4O5S - PubChem
VELUSETRAG
Theravance Biopharma :: SEC Filing
Theravance Biopharma :: SEC Filing
velusetrag | Ligand page | IUPHAR/BPS Guide to PHARMACOLOGY
Clinical trial: the efficacy and tolerability of velusetrag, a selective 5‐HT4 agonist with high intrinsic activity, in chronic idiopathic constipation – a 4‐week, randomized, double‐blind, placebo‐controlled, dose–response study - Goldberg - 2010 -
PDF) Clinical trial: the efficacy and tolerability of velusetrag, a selective 5-HT4 agonist with high intrinsic activity, in chronic idiopathic constipation - a 4-week, randomized, double-blind, placebo-controlled, dose-response study | M. Goldberg -
Full article: Velusetrag for the treatment of chronic constipation
Comparison of efficacy of pharmacological treatments for chronic idiopathic constipation: a systematic review and network meta-analysis | Gut
UNITED STATES SECURITIES AND EXCHANGE COMMISSION FORM 8-K THERAVANCE BIOPHARMA, INC.
Theravance Biopharma Receives FDA Fast Track Designation for Velusetrag (TD-5108) for Idiopathic and Diabetic Gastroparesis
Current developments in pharmacological therapeutics for chronic constipation - ScienceDirect
Buy Velusetrag (bt-285965)| THE BioTek
PDF) Velusetrag for the treatment of chronic constipation
Prokinetics in Phase II and III stages of development | Download Table
Tryptophan Metabolism as a Pharmacological Target: Trends in Pharmacological Sciences
PDF) Velusetrag for the treatment of chronic constipation
Percent change in gastric emptying half‐time from baseline after... | Download Scientific Diagram
Velusetrag accelerates gastric emptying in subjects with gastroparesis: a multicentre, double‐blind, randomised, placebo‐controlled, phase 2 study - Kuo - 2021 - Alimentary Pharmacology & Therapeutics - Wiley Online Library
